ArticleTropical medicine and infectious disease2025
Epidemiology of HIV in Remote Equatorial Regions of Cameroon: High Prevalence in Older Adults and Regional Disparities.
Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Data on HIV prevalence in remote, rural communities of Cameroon are scarce despite the country's high HIV-1 group M diversity. This study assessed HIV seroprevalence and socio-demographic determinants in four regions of the equatorial rainforest location of the country. A cross-sectional survey was conducted among 5631 individuals in rural communities of the Centre, East, Littoral, and South regions. HIV testing was performed, and socio-demographic data were collected. Prevalence ratios (PRs) and adjusted prevalence ratios (aPRs) were estimated using bivariate and multivariate analyses (negative log-binomial model with generalised estimating equations, GEEs). Overall, HIV prevalence was 3.4% (95% CI: 2.9-3.9%) in individuals aged 15-49 years and 4.9% in those aged ≥50 years. Women had higher prevalence than men (4.5% vs. 3.0%, aPR = 1.53, 95% CI: [1.12-2.08],
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.